Once-daily oral GLP-1 receptor agonist Can be taken with or without food or water Helps reduce appetite and supports blood sugar control A convenient alternative for those who prefer tablets over injections Indications: Obesity Overweight with comorbidities such as Type 2 Diabetes or hypertension Common side effects: Nausea, vomiting, diarrhea, constipation, abdominal discomfort, and headache
Convenient In-Clinic Blood Withdrawal and Lab Services We aim to simplify the process of getting your lab work done
Mechanism of Action CJC-1295 works by acting on the GHRH receptor and binding to the pituitary gland receptors to stimulate the release of both GH and insulin-like growth factor 1 (IGF-1)
The mechanisms and applications of GLP-1RAs in SLE remain largely unexplored, and their efficacy and safety need to be validated by further studies
A Key Tool for Weight Loss and Obesity Treatment As a medication, semaglutide mimics glucagon-like peptide-1 (GLP-1)
Employers have a real opportunity to step in, offer these treatments affordably and with dignity, and position themselves as employers of choice. While weighing the choice to cover GLP-1s, employer cost is a significant consideration, Midlam noted